Keyphrases
Glioma
100%
High-grade Glioma
100%
Akt Activation
100%
Ink4a
100%
Mitogen-activated Protein Kinase
60%
Phosphoinositide 3-kinase (PI3K)
40%
Neural Stem Cells
40%
Induced Apoptosis
20%
Mammalian Target of Rapamycin (mTOR)
20%
Tumor
20%
Glioma Therapy
20%
MTOR Inhibitor
20%
Adjuvant Therapy
20%
Tumorigenesis
20%
PD0325901
20%
Tumor Subtype
20%
Extracellular Signal-regulated Kinase
20%
Highly Active
20%
Dual Inhibition
20%
Glioma Mouse Model
20%
Human Glioma Cells
20%
NVP-BEZ235
20%
MEK Inhibitor (MEKi)
20%
Combined Treatment
20%
Biochemistry, Genetics and Molecular Biology
Protein Kinase B
100%
Mitogen-Activated Protein Kinase
100%
Protein Kinase B
100%
Mammalian Target of Rapamycin
66%
Progenitor Cell
66%
Phosphoinositide 3-Kinase
66%
Mouse Model
33%
Extracellular Signal-Regulated Kinases
33%
Phosphotransferase
33%
Kinase
33%
Carcinogenesis
33%
MEK Inhibitor
33%
Programmed Cell Death
33%
Neuroscience
In Vivo
100%
Mitogen-Activated Protein Kinase
75%
Protein Kinase B
75%
Phosphoinositide 3-Kinase
50%
Neural Stem Cell
50%
Kinase
25%
Extracellular Signal-Regulated Kinases
25%
Adjuvant Therapy
25%
Carcinogenesis
25%
MEK Inhibitor
25%
BEZ235
25%
Programmed Cell Death
25%
Medicine and Dentistry
Ganglioglioma
100%
Protein Kinase B
100%
Mitogen-Activated Protein Kinase
44%
Protein Kinase B
33%
Neural Stem Cell
22%
Phosphoinositide 3-Kinase
22%
Phosphotransferase
11%
Neoplasm
11%
Programmed Cell Death
11%
Glioma Cell
11%
Carcinogenesis
11%
MEK Inhibitor
11%
Mammalian Target of Rapamycin Inhibitor
11%
Mammalian Target of Rapamycin
11%
Tumor
11%
Adjuvant Therapy
11%
N (2,3 Dihydroxypropoxy) 3,4 Difluoro 2 (2 Fluoro 4 Iodoanilino)benzamide
11%
BEZ235
11%
Diseases
11%